On this page
PTS
6-pyruvoyltetrahydropterin synthase
The PTS gene provides instructions for making an enzyme essential for producing tetrahydrobiopterin (BH4), a crucial molecule involved in amino acid processing and neurotransmitter synthesis. The PTS gene encodes the enzyme 6-pyruvoyltetrahydropterin synthase, involved in the synthesis of tetrahydrobiopterin (BH4).
PTS is located on the long (q) arm of chromosome 11, at band 11q23.1. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 11 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The PTS gene, also known as 6-pyruvoyltetrahydropterin synthase, is integral to the human metabolic system. It provides the genetic blueprint for an enzyme that plays a critical role in the biosynthesis of tetrahydrobiopterin (BH4), a vital cofactor in several biochemical pathways.
Disruptions in the PTS gene can lead to reduced BH4 production, impacting key bodily functions, particularly those related to brain chemistry and amino acid metabolism. Understanding the PTS gene is important for individuals undergoing carrier screening for inherited metabolic conditions.
What the gene does
The primary function of the PTS gene is to direct the synthesis of the enzyme 6-pyruvoyltetrahydropterin synthase. This enzyme participates in the second step of a three-step pathway responsible for creating tetrahydrobiopterin (BH4). BH4 is an essential cofactor, meaning it helps other enzymes perform their functions effectively.
Specifically, BH4 is crucial for processing various amino acids, which are the building blocks of proteins. For instance, it collaborates with the enzyme phenylalanine hydroxylase to convert phenylalanine into tyrosine. Furthermore, BH4 is involved in the synthesis of neurotransmitters, which are chemical messengers that transmit signals between nerve cells in the brain. Adequate BH4 levels are therefore vital for normal neurological function and metabolic balance.
Video: Genetics 101
Chromosome location
The PTS gene is located on chromosome 11, specifically at position 11q23.1. This precise location on the long arm (q) of chromosome 11 helps define its position within the human genome. The gene contains several exons, which are the coding segments that are ultimately translated into the protein.
Protein structure
The PTS gene encodes a protein that is 145 amino acids in length. Domain architecture has not been experimentally characterised in detail for this protein.
Key variants
Variations within the PTS gene can alter the function or production of the 6-pyruvoyltetrahydropterin synthase enzyme. Over 45 different changes, or mutations, in the PTS gene have been identified. These genetic changes can range from single amino acid substitutions to other types of alterations that impact the enzyme's structure and activity.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.174_175del | p.Val59fs | Pathogenic/Likely pathogenic | ★★☆☆ | 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
c.186+1G>A | - | Pathogenic | ★★☆☆ | 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
c.243G>A | p.Glu81= | Pathogenic/Likely pathogenic | ★★☆☆ | 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
c.245A>G | p.Glu82Gly | Pathogenic/Likely pathogenic | ★★☆☆ | 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
c.314+2T>C | - | Pathogenic/Likely pathogenic | ★★☆☆ | 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
c.315-1G>A | - | Pathogenic/Likely pathogenic | ★★☆☆ | 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
c.331G>A | p.Ala111Thr | Pathogenic/Likely pathogenic | ★★☆☆ | 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
c.342C>G | p.Ile114Met | Pathogenic/Likely pathogenic | ★★☆☆ | 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
c.367C>T | p.Pro123Ser | Pathogenic/Likely pathogenic | ★★☆☆ | 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
c.379C>T | p.Leu127Phe | Pathogenic/Likely pathogenic | ★★☆☆ | 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the PTS gene are primarily associated with a condition known as tetrahydrobiopterin deficiency. When caused by PTS gene variants, this specific type of deficiency is referred to as 6-pyruvoyltetrahydropterin synthase (PTS) deficiency. This condition accounts for more than half of all diagnosed cases of tetrahydrobiopterin deficiency, highlighting the significant role of the PTS gene in this metabolic pathway.
No condition pages are linked to this gene yet. This does not mean it has no associated conditions.
Inheritance pattern
Conditions caused by pathogenic PTS variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
The PTS gene is recognised in the UK by NHS England's Genomic Medicine Service and is included on several NHS Genomic Test Directories. It is listed as 'green' on PanelApp, indicating strong evidence for its association with various conditions. These include Dystonia, chorea or related movement disorder, childhood onset (R57), Early onset or syndromic epilepsy, Foetal anomalies (R21), Intellectual disability, Likely inborn error of metabolism (R98), Neurotransmitter disorders, and Undiagnosed metabolic disorders.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the main role of the PTS gene?
The PTS gene provides instructions for making an enzyme called 6-pyruvoyltetrahydropterin synthase. This enzyme is crucial for the production of tetrahydrobiopterin (BH4), a molecule essential for processing amino acids and synthesising neurotransmitters.
What happens if the PTS gene does not function correctly?
If the PTS gene does not function correctly, it can lead to reduced production of the 6-pyruvoyltetrahydropterin synthase enzyme, resulting in tetrahydrobiopterin (BH4) deficiency. This deficiency can affect amino acid metabolism and the production of neurotransmitters, impacting neurological function.
How common are PTS gene mutations?
Over 45 different mutations in the PTS gene have been identified as causes of tetrahydrobiopterin deficiency. When this condition is caused by PTS gene mutations, it is known as 6-pyruvoyltetrahydropterin synthase (PTS) deficiency, which accounts for more than half of all tetrahydrobiopterin deficiency cases.
References
- Leuzzi V, Carducci CA, Carducci CL. Phenotypic variability, neurological outcome and genetics background of 6-pyruvoyl-tetrahydropterin synthase deficiency. Clinical genetics. 2010. PMID: 20059486
- Longo N. Disorders of biopterin metabolism. Journal of inherited metabolic disease. 2009. PMID: 19234759
- Wang L, Yu WM, He C. Long-term outcome and neuroradiological findings of 31 patients with 6-pyruvoyltetrahydropterin synthase deficiency. Journal of inherited metabolic disease. 2006. PMID: 16601879
- Thöny B, Blau N. Mutations in the BH4-metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase. Human mutation. 2006. PMID: 16917893
- Kao CD, Niu DM, Chen JT. Subtle brain dysfunction in treated 6-pyruvoyl-tetrahydropterin synthase deficiency: relationship to motor tasks and neurophysiological tests. Brain & development. 2004. PMID: 15036427
- Shintaku H. Disorders of tetrahydrobiopterin metabolism and their treatment. Current drug metabolism. 2002. PMID: 12003346
- Dudesek A, Röschinger W, Muntau AC. Molecular analysis and long-term follow-up of patients with different forms of 6-pyruvoyl-tetrahydropterin synthase deficiency. European journal of pediatrics. 2001. PMID: 11388593
- Liu TT, Chiang SH, Wu SJ. Tetrahydrobiopterin-deficient hyperphenylalaninemia in the Chinese. Clinica chimica acta; international journal of clinical chemistry. 2001. PMID: 11694255
- Thöny B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. The Biochemical journal. 2000. PMID: 10727395
- Auerbach G, Nar H. The pathway from GTP to tetrahydrobiopterin: three-dimensional structures of GTP cyclohydrolase I and 6-pyruvoyl tetrahydropterin synthase. Biological chemistry. 1997. PMID: 9165069